Current trends of sutureless and rapid deployment valves: an 11-year experience from the Sutureless and Rapid Deployment International Registry. (1st May 2020)

• Record Type: Journal Article
• Authors: Berretta, Paolo; Arzt, Sebastian; Fiore, Antonio; Carrel, Thierry P; Misfeld, Martin; Teoh, Kevin; Villa, Emmanuel; Albertini, Alberto; Fischlein, Theodor; Martinelli, Gianluca; Shrestha, Malak; Savini, Carlo; Miceli, Antonio; Santarpino, Giuseppe; Andreas, Martin; Mignosa, Carmelo; Phan, Kevin; Meuris, Bart; Solinas, Marco; Yan, Tristan; Di Eusanio, Marco
• Is Part Of: European journal of cardio-thoracic surgery. Volume 58:Number 5(2020)
• Page Start: 1054
• Page End: 1062
• Publication Date: 2020-05-01
• Subjects: Sutureless valve -- Rapid deployment valve -- Aortic valve replacement -- Sutureless and Rapid Deployment International Registry; Heart -- Surgery -- Periodicals; Chest -- Surgery -- Periodicals; 617.54
• DOI: 10.1093/ejcts/ezaa144
• Languages: English
• ISSNs: 1010-7940

Abstract

Abstract: OBJECTIVES: Current evidence on sutureless and rapid deployment aortic valve replacement (SURD-AVR) is limited and does not allow for the assessment of the clinical impact and the evolution of procedural and clinical outcomes of this new valve technology. The Sutureless and Rapid Deployment International Registry (SURD-IR) represents a unique opportunity to evaluate the current trends and outcomes of SURD-AVR interventions. METHODS: Data from 3682 patients enrolled between 2007 and 2018 were analysed. Patients were divided according to the date of surgery into 6 equal groups and by the type of intervention: isolated SURD-AVR ( n = 2472) and combined SURD-AVR ( n = 1086). RESULTS: Across the 11-year study period, significant changes occurred in patient characteristics including a decrease in age and in estimated surgical risk. Less invasive approaches for isolated SURD-AVR increased considerably from 49.4% to 85.5%. The overall in-hospital mortality rate was 1.6% and 3.9% in isolated and combined procedures, respectively, with no change over time. The rate of perioperative stroke decreased significantly (from 4% to 0.5%), as did the rates of postoperative pacemaker implantation (from 12.8% to 5.9%) and aortic regurgitation (from 17.8% to 2.7%). CONCLUSIONS: The present study provides a comprehensive analysis of the current trends and results of SURD-AVR interventions. The most notable changes over time were the increasing implantation of SURD valves in a younger population, with more frequent utilization of less invasive techniques. SURD-AVR demonstrated remarkable improvements in clinical outcomes with a significant reduction in the rates of stroke, pacemaker implantation and postoperative aortic regurgitation.